Profile data is unavailable for this security.
About the company
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
- Revenue in USD (TTM)199.13bn
- Net income in USD5.66bn
- Incorporated2001
- Employees96.13k
- LocationElevance Health Inc220 Virginia AvenueINDIANAPOLIS 46204United StatesUSA
- Phone+1 (317) 488-6000
- Websitehttps://www.elevancehealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Centene Corp | 194.78bn | -6.68bn | 19.96bn | 61.10k | -- | 1.00 | -- | 0.1025 | -13.63 | -13.62 | 394.60 | 40.57 | 2.45 | -- | 10.30 | 3,187,840.00 | -8.39 | 0.4683 | -15.18 | 0.771 | 7.12 | 10.08 | -3.43 | 0.2365 | -- | -0.4145 | 0.4646 | -- | 19.44 | 11.88 | -302.06 | -- | -2.47 | -- |
| Tenet Healthcare Corp | 21.31bn | 1.41bn | 20.31bn | 74.48k | 14.92 | 4.81 | 6.29 | 0.9531 | 15.49 | 15.49 | 234.60 | 48.02 | 0.7271 | 10.89 | 8.06 | -- | 8.08 | 7.28 | 11.63 | 10.40 | 82.26 | 82.59 | 11.11 | 10.10 | 1.68 | 6.61 | 0.5948 | -- | 3.12 | 3.85 | -56.03 | 28.67 | 13.34 | -- |
| Humana Inc | 129.66bn | 1.19bn | 22.20bn | 65.68k | 18.77 | 1.26 | 10.43 | 0.1712 | 9.81 | 9.81 | 1,074.55 | 146.42 | 2.72 | -- | -- | -- | 2.74 | 4.86 | -- | -- | -- | -- | 1.01 | 2.05 | -- | 4.79 | 0.4109 | 19.21 | 10.11 | 10.94 | -1.57 | -18.81 | -10.75 | 3.02 |
| Quest Diagnostics Inc | 11.04bn | 988.00m | 22.76bn | 57.00k | 23.61 | 3.17 | 14.46 | 2.06 | 8.76 | 8.76 | 97.87 | 65.18 | 0.6816 | 39.03 | 8.14 | 193,596.50 | 6.20 | 8.03 | 7.25 | 9.31 | 33.32 | 34.94 | 9.10 | 11.33 | 0.9609 | 6.53 | 0.4377 | 29.29 | 11.78 | 3.18 | 14.09 | -7.06 | 4.74 | 7.68 |
| Labcorp Holdings Inc | 13.77bn | 855.20m | 23.43bn | 70.00k | 27.75 | 2.70 | 15.26 | 1.70 | 10.18 | 10.18 | 163.87 | 104.78 | 0.7466 | 19.61 | 6.13 | 196,647.10 | 4.64 | 6.16 | 5.56 | 7.33 | 28.45 | 32.18 | 6.22 | 9.17 | 1.35 | 5.51 | 0.3934 | -- | 6.97 | 2.40 | 96.73 | -1.96 | 4.13 | -- |
| Natera Inc | 2.12bn | -309.19m | 28.70bn | 4.42k | -- | 22.65 | -- | 13.56 | -2.28 | -2.28 | 15.69 | 9.10 | 1.24 | 13.57 | 7.14 | 478,452.50 | -18.12 | -30.60 | -23.17 | -38.82 | 63.66 | 51.43 | -14.61 | -40.61 | 3.13 | -- | 0.0603 | -- | 56.75 | 41.20 | 56.20 | -- | 72.97 | -- |
| Elevance Health Inc | 199.13bn | 5.66bn | 76.54bn | 96.13k | 13.81 | 1.74 | 10.53 | 0.3844 | 25.11 | 25.11 | 886.67 | 198.81 | 1.67 | -- | -- | 2,071,435.00 | 4.75 | 5.60 | -- | -- | -- | -- | 2.84 | 3.52 | -- | 5.79 | 0.4213 | 22.92 | 12.62 | 10.32 | -5.32 | 4.37 | 1.80 | 12.47 |
| Cigna Group | 268.08bn | 6.15bn | 76.78bn | 73.50k | 12.83 | 1.86 | 8.30 | 0.2864 | 22.71 | 22.71 | 988.52 | 156.81 | 1.70 | 45.26 | 9.00 | 3,647,306.00 | 4.15 | 3.91 | 6.50 | 5.49 | 9.55 | 12.70 | 2.44 | 3.12 | 0.7281 | 7.89 | 0.4476 | 19.80 | 26.56 | 9.98 | -33.50 | -7.62 | 6.01 | 169.72 |
| CVS Health Corp | 402.07bn | 1.77bn | 99.84bn | 300.00k | 57.39 | 1.33 | 15.76 | 0.2483 | 1.37 | 1.37 | 316.03 | 59.18 | 1.59 | 18.56 | 39.33 | 1,340,223.00 | 0.682 | 2.24 | 1.04 | 3.26 | 13.77 | 15.33 | 0.4298 | 1.55 | 0.6254 | 3.98 | 0.4614 | 57.26 | 7.85 | 8.39 | -61.68 | -24.46 | 3.05 | 5.87 |
| HCA Healthcare Inc | 75.60bn | 6.78bn | 120.82bn | 230.00k | 19.03 | -- | 10.69 | 1.60 | 28.39 | 28.39 | 315.61 | -26.83 | 1.26 | 6.71 | 6.99 | 328,695.70 | 12.94 | 12.85 | 18.89 | 17.60 | 84.96 | 84.59 | 10.29 | 10.63 | 0.8643 | 5.51 | 1.06 | 10.90 | 7.08 | 7.97 | 17.78 | 12.56 | 11.76 | -- |
| UnitedHealth Group Inc | 447.57bn | 12.06bn | 265.58bn | 400.00k | 22.22 | 2.65 | 15.47 | 0.5934 | 13.19 | 13.19 | 491.02 | 110.49 | 1.47 | -- | -- | -- | 4.21 | 6.98 | -- | -- | -- | -- | 2.86 | 4.89 | -- | 4.74 | 0.4353 | 38.70 | 11.81 | 11.72 | -16.31 | -4.78 | 12.05 | 12.57 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 20.75m | 9.34% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 11.76m | 5.29% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 10.34m | 4.65% |
| Wellington Management Co. LLPas of 30 Sep 2025 | 6.21m | 2.79% |
| Sanders Capital LLCas of 31 Dec 2025 | 5.75m | 2.59% |
| T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2025 | 5.50m | 2.48% |
| Geode Capital Management LLCas of 31 Dec 2025 | 5.12m | 2.31% |
| Artisan Partners LPas of 30 Sep 2025 | 4.58m | 2.06% |
| First Eagle Investment Management LLCas of 31 Dec 2025 | 4.02m | 1.81% |
| Harris Associates LPas of 30 Sep 2025 | 3.19m | 1.44% |
